logo
Share SHARE
FONT-SIZE Plus   Neg

William Baird Named CFO Of Amicus Therapeutics - Quick Facts

Amicus Therapeutics Inc. (FOLD), a biopharmaceutical company, said it has named William "Chip" Baird, III as chief financial officer, effective today. Baird, with over 15 years of experience in finance and strategic planning, would be responsible for all Finance, Accounting and Investor Relations activities.

Baird, who joins Amicus from PTC Therapeutics Inc., would report directly to Chairman and Chief Executive, John Crowley. He worked at PTC for more than 10 years in positions of increasing responsibility.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
RELATED NEWS
Trade FOLD now with 
Follow RTT